132 related articles for article (PubMed ID: 24360843)
1. A rare but severe complication of filgrastim in a healthy donor: splenic rupture.
Akyol G; Pala C; Yildirim A; Keklika M; Demir K; Dortdudak S; Sivgin S; Kaynar L; Esera B; Unal A; Cetin M
Transfus Apher Sci; 2014 Feb; 50(1):53-5. PubMed ID: 24360843
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous subcapsular splenic hematoma associated with filgrastim in a patient undergoing allogeneic hematopoietic stem cell transplantation.
Ganetsky A; Kucharczuk C; Del Percio S; Frey N; Gill S
Ann Pharmacother; 2013 May; 47(5):e22. PubMed ID: 23585644
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
Nuamah NM; Goker H; Kilic YA; Dagmoura H; Cakmak A
Haematologica; 2006 May; 91(5 Suppl):ECR08. PubMed ID: 16709516
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
5. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.
Veerappan R; Morrison M; Williams S; Variakojis D
Bone Marrow Transplant; 2007 Aug; 40(4):361-4. PubMed ID: 17563733
[TBL] [Abstract][Full Text] [Related]
6. Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.
Stiff PJ; Bensinger W; Abidi MH; Gingrich R; Artz AS; Nademanee A; Hansen KS; Sobczak C; Cutler C; Bolwell B; Shore TB; Lazarus HM; Yeager AM; Lovelace W; Guo M; Dreiling L
Biol Blood Marrow Transplant; 2009 Jul; 15(7):827-34. PubMed ID: 19539214
[TBL] [Abstract][Full Text] [Related]
7. Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor.
Balaguer H; Galmes A; Ventayol G; Bargay J; Besalduch J
Transfusion; 2004 Aug; 44(8):1260-1. PubMed ID: 15265137
[No Abstract] [Full Text] [Related]
8. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
9. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
10. Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation.
Kasper C; Jones L; Fujita Y; Morgenstern GR; Scarffe JH; Chang J
Ann Hematol; 1999 Feb; 78(2):91-2. PubMed ID: 10089026
[TBL] [Abstract][Full Text] [Related]
11. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.
Dincer AP; Gottschall J; Margolis DA
J Pediatr Hematol Oncol; 2004 Nov; 26(11):761-3. PubMed ID: 15543014
[TBL] [Abstract][Full Text] [Related]
12. Splenic rupture following lenograstim in post-autologous stem cell transplantation treated with emergency open splenectomy: a case report and literature review.
Markovic U; Colarossi C; Iuppa A; Scire P; Gorgone A; Galbo F; Amato G; Moschetti G
J Int Med Res; 2022 May; 50(5):3000605221095504. PubMed ID: 35638556
[TBL] [Abstract][Full Text] [Related]
13. Splenic rupture in a plasma cell leukemia, mobilized with G-CSF for autologous stem cell transplant.
Funes C; Garcia-Candel F; Majado MJ; González-García C; Bas A; Salido E; Moraleda JM; Morales A
J Clin Apher; 2010; 25(4):223-5. PubMed ID: 20818717
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor.
Falzetti F; Aversa F; Minelli O; Tabilio A
Lancet; 1999 Feb; 353(9152):555. PubMed ID: 10028986
[No Abstract] [Full Text] [Related]
15. Spontaneous splenic rupture following stem cell mobilization with G-CSF and plerixafor in AL amyloidosis.
Lessi F; Marson P; Colpo A; Marino F; Branca A; Tison T; Adami F
Transfus Apher Sci; 2016 Apr; 54(2):256-8. PubMed ID: 26458962
[TBL] [Abstract][Full Text] [Related]
16. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
[TBL] [Abstract][Full Text] [Related]
17. Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization.
Picardi M; De Rosa G; Selleri C; Scarpato N; Soscia E; Martinelli V; Ciancia R; Rotoli B
Haematologica; 2003 Jul; 88(7):794-800. PubMed ID: 12857559
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
Becker PS; Wagle M; Matous S; Swanson RS; Pihan G; Lowry PA; Stewart FM; Heard SO
Biol Blood Marrow Transplant; 1997 Apr; 3(1):45-9. PubMed ID: 9209740
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
[TBL] [Abstract][Full Text] [Related]
20. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
